Latest / Durham News Today | 2 Min News | The Daily News Now!
Lilly’s New Weight Pill Gets U.K. Approval | Durham News
Eli Lilly’s new daily pill Foundayo just got U.K. approval — a major win as its first oral weight and diabetes drug in Europe. With no needles required and flexible dosing, it could unlock a massive market of patients avoiding injections. The GLP-1 drug orforglipron delivers real weight loss — up to 11.2% in trials — plus heart health benefits, without strict food rules. While Novo Nordisk already has an oral option, Foundayo’s lower price and potential NHS coverage could make it a game-changer — with a final decision expected in November 2026. Listen in comfort:Get a discount on a Soli…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.